By: Christina England 15 November 2010 A few days ago, the Daily Express ran an article which stated that cancer expert Professor Peter Sasieni recommended phasing out smear tests in favour of HPV testing. The opening statement in Victoria Fletcher’s article ‘New Cancer Check To Phase Out Smear Tests’ (http://www.express.co.uk/posts/view/210613/New-cancer-check-to-phase-out-smear-tests)read : “SMEAR tests for cervical […]
South Africans develop tool to detect cervical cancer
By: Melody Brandon 05 November 2010 JOHANNESBURG (Xinhua) — A team of South African students from the University of The Witwatersrand (WITS) have used “biological Lego” to develop a tool that is hoped to detect cervical cancer. According to the South African department of Health, cancer of the cervix is the second most common […]
**Exclusive: GlaxoSmithKline and the Promotion of the Cervarix Vaccine
By: Bob Fiddaman 02 November 2010 As a writer I am sent many links to news stories, some I have already covered, others have been covered many times by far greater writer’s than I. Imagine my surprise then when I, along with a few other writer’s, activists, campaigners, was sent a promotional DVD for GlaxoSmithKline’s […]
GlaxoSmithKline Drops the Price of Cervarix
Source: PharmaLive 25 October 2010 Today, GlaxoSmithKline Inc. (Canada), announced its plan to reduce the cost of CERVARIX™ by 30%. The cost reduction is in response to recent research that demonstrates the relatively high price of cervical cancer vaccines, coupled with a low understanding of their protective benefits topped the list of reasons why the […]
Cervarix licence extended
Published in HealthcareRepublic 01 October 2010 The marketing authorisation for Cervarix has been updated to show that it offers broader protection against human papillomavirus (HPV) than first thought. Read the entire article here.
- « Previous Page
- 1
- …
- 56
- 57
- 58
- 59
- 60
- …
- 112
- Next Page »